Insider Holders & Insider Ownership - Myovant Sciences Ltd. (MYOV)

List of insiders holdings for Myovant Sciences Ltd.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
#Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
1Sumitomo Chemical Co. Ltd.
Sumitomo Pharma Co. Ltd.
Sumitovant Biopharma Ltd.
10% Owner		2023-03-10 09:29:5645,798,176
0		45,798,176Form 13D
2MILLENNIUM PHARMACEUTICALS INC
Takeda Pharmaceuticals U.S.A. Inc.
10% Owner		2018-03-29 20:50:407,420,625
0		7,420,625Form 3
3Takeda Pharmaceuticals International AG
TAKEDA PHARMACEUTICAL CO LTD
Takeda A/S
Takeda Europe Holdings B.V.
Takeda Pharma A/S
10% Owner		2020-01-24 06:16:373,920,625
0		3,920,625Form 13G
4Seely Lynn
Principal Executive Officer		2020-04-07 17:16:331,346,517
846,168		2,192,685Form 4
5Sablich Kim
Chief Commercial Officer		2020-04-07 17:14:42281,174
0		281,174Form 4
6KARBE FRANK
Principal Fin'l & Accounting		2021-07-09 16:27:07212,296
0		212,296Form 4
7Torti Frank
Director		2019-08-27 16:50:5658,608
0		58,608Form 4
8DeVeydt Wayne S
Director		2017-10-20 16:46:5122,500
0		22,500Form 4
9Altmeyer Mark
Director		2018-09-04 16:44:4422,500
0		22,500Form 4
10Sebelius Kathleen
Director		2020-09-17 16:12:0021,603
0		21,603Form 4
11Romeo Marianne L.
Head,Global Trans. & Risk Mgmt		2016-10-26 20:11:1214,102
0		14,102Form 3
12Gulfo Adele M.
Director		2023-03-10 09:28:580
0		0Form 4
13Arjona Ferreira Juan Camilo
Chief Medical Officer		2023-03-10 09:24:590
0		0Form 4
14Curran Terrie
Director		2023-03-10 09:27:330
0		0Form 4
15GUINAN MARK
Director		2023-03-10 09:28:180
0		0Form 4
16Roivant Sciences Ltd.
10% Owner		2019-12-31 16:45:460
0		0Form 4
17Lang Matthew
General Counsel & Corp. Secy.		2023-03-10 09:29:360
0		0Form 4
18Marek David C
Principal Executive Officer		2023-03-10 09:30:130
0		0Form 4
19Mehra Uneek
Principal Financial Officer		2023-03-10 09:31:050
0		0Form 4
20Merendino Lauren
Chief Commercial Officer		2023-03-10 09:31:440
0		0Form 4
21POTTER MYRTLE S
Director		2023-03-10 09:32:180
0		0Form 4
22Valente Nancy
Director		2023-03-10 09:32:520
0		0Form 4
23Nishinaka Shigeyuki
Director		2022-10-21 17:15:290
0		0Form 3
24Nomura Hiroshi
Director		2019-12-30 17:15:030
0		0Form 3
25Lo Andrew
Former 10% Owner		2019-07-16 17:42:170
0		0Form 13D
26Machado Patrick
Former 10% Owner		2019-07-16 17:31:170
0		0Form 13D
27Dexxon Holdings Ltd.
Dexcel Pharma Technologies Ltd.
Oren Dan
See remarks		2019-07-12 16:52:120
0		0Form 4
28VIKING GLOBAL PERFORMANCE LLC
Viking Global Equities LP
Viking Global Equities II LP
VGE III Portfolio Ltd.
Viking Global Equities Master Ltd.
Viking Long Fund GP LLC
Viking Long Fund Master Ltd.
HALVORSEN OLE ANDREAS
Ott David C.
Shabet Rose Sharon
Former 10% Owner		2019-07-12 20:34:360
0		0Form 4
29VIKING GLOBAL INVESTORS LP
Viking Global Opportunities Illiquid Investments Sub-Master LP
Viking Global Opportunities Portfolio GP LLC
Viking Global Opportunities GP LLC
HALVORSEN OLE ANDREAS
Ott David C.
Shabet Rose Sharon
Former 10% Owner		2019-07-12 20:33:270
0		0Form 4
30SVF Investments (UK) Ltd
SoftBank Vision Fund L.P.
SVF Holdings (UK) LLP
SVF GP (Jersey) Ltd
Former 10% Owner		2019-07-12 19:50:260
0		0Form 4
31QVT Associates GP LLC
QVT Fund V LP
10% Owner		2019-07-12 16:28:550
0		0Form 4
32VIKING GLOBAL INVESTORS LP
Viking Global Opportunities Illiquid Investments Sub-Master LP
Viking Global Opportunities Portfolio GP LLC
Viking Global Opportunities GP LLC
HALVORSEN OLE ANDREAS
Ott David C.
Sundheim Daniel S.
10% Owner		2019-07-12 16:59:530
0		0Form 13D
33Ramaswamy Vivek
Director		2016-10-26 20:17:400
0		0Form 3
34MANCHESTER KEITH S
Director		2016-10-26 20:13:550
0		0Form 3